Companies: 10,795·Total market cap: $144.5T
MEI Pharma, Inc.

MEI Pharma, Inc.

MEIPNASDAQHealthcare
$3.07
+$0.29(+10.43%)
Market Cap$20452012
P/E Ratio
52W High$9
52W Low$1.46

MEI Pharma, Inc.(MEIP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MEIP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$0.00B$0.07B$0.05B$0.04B$0.03B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.06B$0.05B$0.04B$0.02B
Gross Margin %(computed)99.41%96.28%100.00%94.49%
Operating Expenses
R&D Expenses$0.00B$0.02B$0.05B$0.09B$0.07B
G&A Expenses$0.01B$0.02B$0.03B$0.03B$0.02B
Total Operating Expenses$0.02B$0.03B$0.04B$0.12B$0.09B
Operating Income($0.02B)$0.01B($0.04B)($0.08B)($0.06B)
Operating Margin %(computed)22.27%-75.31%-185.48%-236.63%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.02B)$0.02B($0.03B)($0.05B)($0.04B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.02B)$0.02B($0.03B)($0.05B)($0.04B)
Net Margin %(computed)27.23%-65.22%-133.79%-161.78%
Per Share & EBITDA
EPS (Basic)$-2.39$2.67$-4.78$-8.75$-7.34
Wtd Avg Shares0.01B0.01B0.01B0.01B0.01B
EBITDA($0.02B)$0.03B($0.03B)($0.08B)($0.06B)
EBITDA Margin %(computed)40.40%-67.15%-184.68%-235.52%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解MEI Pharma, Inc.

关于MEI Pharma, Inc.(MEIP)损益表

MEI Pharma, Inc.(MEIP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MEIP实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.02B)(净利率—)。

常见问题

MEIP · 4 问

MEI Pharma, Inc.(MEIP)2025财年营收为$0.00B,同比down100.0%。

MEIP revenueMEIP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09